Effects of TNF inhibitors and an IL12/23 inhibitor on changes in body weight and adipokine levels in psoriasis patients: A 48-week comparative study.

Nahide OnsunTahsin Çağdaş AkaslanKadriye SallahogluAliye Sevdem GülcanHuri BulutAyşegül Yabacı

Published in: The Journal of dermatological treatment (2021)

Unlike TNF inhibitors, ustekinumab does not cause significant weight changes and it increases adipokine levels more than TNF inhibitors. Adipokine levels seem to be related to the treatment response.

Keyphrases

body weight
rheumatoid arthritis
end stage renal disease
chronic kidney disease
ejection fraction
body mass index
peritoneal dialysis
prognostic factors
physical activity
randomized controlled trial
clinical trial
patient reported
drug induced